Virtu Financial LLC Buys Shares of 48,341 Enzo Biochem, Inc. (NYSE:ENZ)

Virtu Financial LLC purchased a new stake in shares of Enzo Biochem, Inc. (NYSE:ENZ) during the 4th quarter, Holdings Channel.com reports. The fund purchased 48,341 shares of the medical research company’s stock, valued at approximately $35,000.

Separately, Lepercq Multi Asset Fund purchased a new position in shares of Enzo Biochem during the 4th quarter worth $88,000. 36.90% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Separately, StockNews.com initiated coverage on Enzo Biochem in a research report on Monday. They issued a “hold” rating for the company.

Enzo Biochem Trading Down 12.2 %

Shares of ENZ stock opened at $0.33 on Wednesday. The stock has a fifty day simple moving average of $0.52 and a two-hundred day simple moving average of $0.82. Enzo Biochem, Inc. has a 52-week low of $0.31 and a 52-week high of $1.30.

Enzo Biochem (NYSE:ENZ) last announced its quarterly earnings results on Monday, March 17th. The medical research company reported ($0.02) EPS for the quarter. Enzo Biochem had a negative return on equity of 7.96% and a negative net margin of 75.34%. The company had revenue of $7.33 million during the quarter.

Enzo Biochem Profile

Enzo Biochem, Inc develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.